Literature DB >> 6786460

Remission of primary pulmonary hypertension during treatment with diazoxide.

D R Hall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6786460      PMCID: PMC1505034          DOI: 10.1136/bmj.282.6270.1118

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance.

Authors:  D T DRESDALE; R J MICHTOM; M SCHULTZ
Journal:  Bull N Y Acad Med       Date:  1954-03

2.  Primary pulmonary hypertension favorable effect of isoproterenol.

Authors:  U R Shettigar; H N Hultgren; M Specter; R Martin; D H Davies
Journal:  N Engl J Med       Date:  1976-12-16       Impact factor: 91.245

3.  Diazoxide in treatment of primary pulmonary hypertension.

Authors:  S W Wang; J E Pohl; D J Rowlands; E G Wade
Journal:  Br Heart J       Date:  1978-05

4.  Oral hydralazine therapy for primary pulmonary hypertension.

Authors:  L J Rubin; R H Peter
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

5.  Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.

Authors:  M Honey; L Cotter; N Davies; D Denison
Journal:  Thorax       Date:  1980-04       Impact factor: 9.139

  5 in total
  5 in total

1.  Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.

Authors:  D R Hall; M C Petch
Journal:  Br Heart J       Date:  1987-10

Review 2.  Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.

Authors:  K F Chung; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-09

3.  Vasodilator therapy of pulmonary hypertension in the CRST syndrome.

Authors:  J McWeeney; P Finnegan
Journal:  Ir J Med Sci       Date:  1982-05       Impact factor: 1.568

4.  Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.

Authors:  N S Chan; J McLay; A C Kenmure
Journal:  Br Heart J       Date:  1987-02

5.  Rapid recurrence of pulmonary hypertension following cessation of nifedipine.

Authors:  M M Gallagher; C M Hart; C J Vaughan; W H Fennell
Journal:  Postgrad Med J       Date:  1998-02       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.